Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC
Abstract An association between angiogenesis/inflammation status and tumor has been reported in various types of cancer. This study sought to assess the role of peripheral blood VEGF and some inflammation biomarkers in evaluating clinical response and prognosis in patients with non-operative esophag...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a957319f4a154db9894514502594b681 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a957319f4a154db9894514502594b681 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a957319f4a154db9894514502594b6812021-12-02T18:47:04ZCombined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC10.1038/s41598-021-94329-82045-2322https://doaj.org/article/a957319f4a154db9894514502594b6812021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94329-8https://doaj.org/toc/2045-2322Abstract An association between angiogenesis/inflammation status and tumor has been reported in various types of cancer. This study sought to assess the role of peripheral blood VEGF and some inflammation biomarkers in evaluating clinical response and prognosis in patients with non-operative esophageal squamous cell carcinoma (ESCC). Peripheral blood of 143 patients with non-operative ESCC at our institute was dynamically collected at 5 time points including 1 day before radiotherapy, during radiotherapy (15f), at the end of radiotherapy, 1 month after radiotherapy, and 3 months after radiotherapy. VEGF expression in the peripheral blood was detected and related inflammation biomarkers such as GPS, CAR and CLR were counted. Logistic regression and Cox regression were implemented respectively to analyze the correlation of each predictor with clinical response and prognosis. The performance of combined testing was estimated using AUCs. Based on independent predictors, a nomogram prediction model was established to predict the probabilities of 1- and 2-year PFS of patients. The effectiveness of the nomogram model was characterized by C-index, AUC, calibration curves and DCA. VEGF and CLR levels at the end of radiotherapy were independent predictors of clinical response, while VEGF and GPS levels at 3 months after radiotherapy were independent prognostic predictors. The efficacy of combined detection of VEGF and CLR is superior to the single detection in evaluating clinical response and prognosis. The nomogram showed excellent accuracy in predicting PFS. The combined detection of VEGF and CLR at the end of radiotherapy can be used to evaluate the clinical response of patients with non-operative ESCC, and the combined detection of VEGF and GPS 3 months after radiotherapy can be used to predict the prognosis. Implemented by nomogram model, it is expected to provide practical and reliable method to evaluate the clinical response and prognosis of patients with non-operative ESCC tool.Yuanyuan MaXinyu SuXin LiXiaohui ZhiKan JiangJianhong XiaHongliang LiChen YanLiqing ZhouNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Yuanyuan Ma Xinyu Su Xin Li Xiaohui Zhi Kan Jiang Jianhong Xia Hongliang Li Chen Yan Liqing Zhou Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC |
description |
Abstract An association between angiogenesis/inflammation status and tumor has been reported in various types of cancer. This study sought to assess the role of peripheral blood VEGF and some inflammation biomarkers in evaluating clinical response and prognosis in patients with non-operative esophageal squamous cell carcinoma (ESCC). Peripheral blood of 143 patients with non-operative ESCC at our institute was dynamically collected at 5 time points including 1 day before radiotherapy, during radiotherapy (15f), at the end of radiotherapy, 1 month after radiotherapy, and 3 months after radiotherapy. VEGF expression in the peripheral blood was detected and related inflammation biomarkers such as GPS, CAR and CLR were counted. Logistic regression and Cox regression were implemented respectively to analyze the correlation of each predictor with clinical response and prognosis. The performance of combined testing was estimated using AUCs. Based on independent predictors, a nomogram prediction model was established to predict the probabilities of 1- and 2-year PFS of patients. The effectiveness of the nomogram model was characterized by C-index, AUC, calibration curves and DCA. VEGF and CLR levels at the end of radiotherapy were independent predictors of clinical response, while VEGF and GPS levels at 3 months after radiotherapy were independent prognostic predictors. The efficacy of combined detection of VEGF and CLR is superior to the single detection in evaluating clinical response and prognosis. The nomogram showed excellent accuracy in predicting PFS. The combined detection of VEGF and CLR at the end of radiotherapy can be used to evaluate the clinical response of patients with non-operative ESCC, and the combined detection of VEGF and GPS 3 months after radiotherapy can be used to predict the prognosis. Implemented by nomogram model, it is expected to provide practical and reliable method to evaluate the clinical response and prognosis of patients with non-operative ESCC tool. |
format |
article |
author |
Yuanyuan Ma Xinyu Su Xin Li Xiaohui Zhi Kan Jiang Jianhong Xia Hongliang Li Chen Yan Liqing Zhou |
author_facet |
Yuanyuan Ma Xinyu Su Xin Li Xiaohui Zhi Kan Jiang Jianhong Xia Hongliang Li Chen Yan Liqing Zhou |
author_sort |
Yuanyuan Ma |
title |
Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC |
title_short |
Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC |
title_full |
Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC |
title_fullStr |
Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC |
title_full_unstemmed |
Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC |
title_sort |
combined detection of peripheral blood vegf and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative escc |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/a957319f4a154db9894514502594b681 |
work_keys_str_mv |
AT yuanyuanma combineddetectionofperipheralbloodvegfandinflammationbiomarkerstoevaluatetheclinicalresponseandprognosticpredictionofnonoperativeescc AT xinyusu combineddetectionofperipheralbloodvegfandinflammationbiomarkerstoevaluatetheclinicalresponseandprognosticpredictionofnonoperativeescc AT xinli combineddetectionofperipheralbloodvegfandinflammationbiomarkerstoevaluatetheclinicalresponseandprognosticpredictionofnonoperativeescc AT xiaohuizhi combineddetectionofperipheralbloodvegfandinflammationbiomarkerstoevaluatetheclinicalresponseandprognosticpredictionofnonoperativeescc AT kanjiang combineddetectionofperipheralbloodvegfandinflammationbiomarkerstoevaluatetheclinicalresponseandprognosticpredictionofnonoperativeescc AT jianhongxia combineddetectionofperipheralbloodvegfandinflammationbiomarkerstoevaluatetheclinicalresponseandprognosticpredictionofnonoperativeescc AT hongliangli combineddetectionofperipheralbloodvegfandinflammationbiomarkerstoevaluatetheclinicalresponseandprognosticpredictionofnonoperativeescc AT chenyan combineddetectionofperipheralbloodvegfandinflammationbiomarkerstoevaluatetheclinicalresponseandprognosticpredictionofnonoperativeescc AT liqingzhou combineddetectionofperipheralbloodvegfandinflammationbiomarkerstoevaluatetheclinicalresponseandprognosticpredictionofnonoperativeescc |
_version_ |
1718377697807171584 |